terminal phase
Showing 1 - 25 of >10,000
Amputation Trial (Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees)
Not yet recruiting
- Amputation
- Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees
- (no location specified)
Mar 21, 2022
Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)
Recruiting
- Solid Tumor, Childhood
- +2 more
-
Boston, Massachusetts
- +5 more
Dec 27, 2022
Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)
Not yet recruiting
- Solid Tumor, Adult
- HB0045 Drug Product
-
Boston, Massachusetts
- +2 more
Sep 20, 2023
Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)
Not yet recruiting
- Solid Tumor, Adult
- HB0045 Drug Product
-
Boston, Massachusetts
- +2 more
Jul 5, 2023
AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)
Terminated
- AML Including AML de Novo and AML Secondary to MDS
- DLBCL
- Birabresib Dose 20 mg
- (no location specified)
Aug 23, 2022
Depressive Symptoms, Depression, Anxiety, Psychological Distress Trial in Ottawa (repetitive Transcranial Magnetic Stimulation
Recruiting
- Depressive Symptoms
- +3 more
- repetitive Transcranial Magnetic Stimulation (rTMS)
-
Ottawa, Ontario, CanadaElisabeth Bruyère Hospital
Dec 31, 2022
Terminal Malignant Tumors Trial in Changchun (TQB2858 injection)
Recruiting
- Terminal Malignant Tumors
- TQB2858 injection
-
Changchun, Jilin, ChinaJinlin Cancer Hospital
Jun 2, 2021
Prevalence of Deep Sedation in Terminal Palliative Phase
Completed
- Palliative Care
- Deep Sedations
- Type of sedations
-
Bordeaux, Aquitaine, FranceCentre Hospitalier Universitaire de Bordeaux - St André
Jan 20, 2021
NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)
Terminated
- NUT Midline Carcinoma (NMC)
- +3 more
- (no location specified)
Jan 7, 2021
Healthcare Associated Infection, Clostridium Difficile Infection, Infection Due to Multidrug Resistant Bacteria Trial in Detroit
Completed
- Healthcare Associated Infection
- +2 more
- Pulsed xenon ultraviolet (PX-UV) Device
- Sham Device
-
Detroit, MichiganDetroit Medical Center
Feb 16, 2022
Palliative Care, Terminal Care, Medication Therapy Management Trial in Netherlands (CDSS-OPTIMED)
Recruiting
- Palliative Care
- +4 more
- CDSS-OPTIMED
-
Alkmaar, Netherlands
- +6 more
Aug 18, 2022
Metastatic Pancreatic Cancer, Terminal Cancer Trial in Shanghai (Ascorbate)
Recruiting
- Metastatic Pancreatic Cancer
- Terminal Cancer
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
Pre-terminal Cancer Trial (Heart failure medication, Placebo)
Not yet recruiting
- Pre-terminal Cancer
- Heart failure medication
- Placebo
- (no location specified)
Dec 5, 2022
Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)
Recruiting
- Advanced Solid Tumors Cancer
-
New Haven, Connecticut
- +29 more
Dec 5, 2022
Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)
Active, not recruiting
- Covid19
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 31, 2022
Advanced Solid Tumor Trial in Shanghai (HY-0102)
Not yet recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 19, 2023
Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 -Dose Expansion
- (no location specified)
Dec 1, 2023
Heart Failure, Left Ventricular Systolic Dysfunction Trial (Vericiguat tablet, Vericiguat suspension, Placebo tablet)
Not yet recruiting
- Heart Failure
- Left Ventricular Systolic Dysfunction
- Vericiguat tablet
- +3 more
- (no location specified)
Jan 26, 2023